janus kinase (JAK) inhibitor living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

6490	Kaplanski, 2020	0	30	0	selection pending
9239	Tziolos, 2021	1	13	0		not a RCT	risk of bias not avaialble